v3.26.1
Taxation (Tables)
12 Months Ended
Dec. 31, 2025
Taxation [Abstract]  
Schedule of Income Tax Provision

The income tax provision consisted of the following components:

 

   For the years ended December 31, 
   2023   2024   2025 
Current income tax expense  $1,871   $1,618   $1,353 
Deferred income tax expense/(benefit)   701    1,235    (1,007)
Total income tax expense  $2,572   $2,853   $346 
Schedule of Provision for Income Taxes and the Provision at the PRC, Mainland Statutory Rate

A reconciliation between the Group’s actual provision for income taxes and the provision at the PRC, mainland statutory rate is as follows:

 

   For the years ended December 31, 
   2023   2024   2025 
(Loss)/income before income tax expense  $(15,007)  $(61,600)  $(2,053)
Computed income tax (benefit)/expense with statutory tax rate   (3,752)   (15,400)   (513)
Additional deduction for research and development expenses   (546)   (439)   (552)
Tax effect of preferred tax rate   2,264    15,696    791 
Tax effect of favorable tax rates on small-scale and low-profit entities   (92)   18    (19)
Tax effect of tax relief   (2)   
-
    
-
 
Tax effect of non-deductible items   77    76    141 
Tax effect of expired tax attribute carryforwards   165    523    1,093 
Tax effect of deferred tax effect of tax rate change   (40)   
-
    
-
 
Changes in valuation allowance   4,498    2,379    (595)
Income tax expense  $2,572   $2,853   $346 
Schedule of Deferred Tax Assets

As of December 31, 2024 and 2025, the significant components of the deferred tax assets are summarized below:

 

   As of December 31, 
   2024   2025 
Deferred tax assets:        
Temporary difference in accounts receivable recognition  $5,570   $5,815 
Temporary difference in research and development costs   3,033    2,995 
Accrued expense   391    408 
Net operating loss carried forward   11,325    11,961 
Share-based compensation   295    538 
Allowance for credit losses   3,679    4,033 
Total deferred tax assets   24,293    25,750 
Valuation allowance   (13,840)   (13,803)
Deferred tax assets, net of valuation allowance  $10,453   $11,947 
Schedule of Changes in Valuation Allowance

Changes in valuation allowance are as follows:

 

   As of December 31, 
   2024   2025 
Balance at the beginning of the year  $11,820   $13,840 
Additions/(Reversals)   2,344    (642)
Foreign currency translation adjustments   (324)   605 
Balance at the end of the year  $13,840   $13,803 
Schedule of Net Operating Loss Carryforwards

As of December 31, 2025, net operating loss carryforwards will expire, if unused, in the following amounts:

 

2026  $4,643 
2027   16,976 
2028   14,288 
2029   6,664 
2030   6,805 
Indefinite   87,396 
Total  $136,772